Pneumonia
An analysis of oral antibiotic regimens dispensed to healthy outpatients with community-acquired pneumonia (CAP) in 2007 through 2019 found that 48% got broad-spectrum drugs and that they had significantly higher rates of adverse drug events than patients who got macrolide monotherapy.